Lp-PLA2-IN-3
Lp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2) [1].
Product Specifications
CAS Number
[2196245-16-4]
UNSPSC
12352005
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/lp-pla2-in-3.html
Purity
99.94
Solubility
DMSO : ≥ 250 mg/mL
Smiles
O=S(C1=CC=C(N)C=C1)(NC2=CC=C(OC3=CC=C(Cl)C(C(F)(F)F)=C3)C(C#N)=C2)=O
Molecular Formula
C20H13ClF3N3O3S
Molecular Weight
467.85
References & Citations
[1]Liu Q, et al. Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. J Med Chem. 2017 Dec 28;60 (24) :10231-10244.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1121578-01 0.02 mg (E-Coli)
Recombinant Klebsiella pneumoniae Protein CsiD (csiD)
Ask
View Details 
MBS1121578-02 0.02 mg (Yeast)
Recombinant Klebsiella pneumoniae Protein CsiD (csiD)
Ask
View Details MBS1121578-03 0.1 mg (E-Coli)
Recombinant Klebsiella pneumoniae Protein CsiD (csiD)
Ask
View Details 